Clinical trial

Soy Protein Supplement In Treating Hot Flashes in Postmenopausal Women Receiving…

NCT00031720 · Alliance for Clinical Trials in Oncology, Other · Completed

Key facts

NCT number NCT00031720
Title Soy Protein Supplement In Treating Hot Flashes in Postmenopausal Women Receiving Tamoxifen for Breast Disease
Official title Phase II Study of Soy Protein to Treat Vasomotor Symptoms in Postmenopausal Women Taking Tamoxifen
Lead sponsor Alliance for Clinical Trials in Oncology, Other
Collaborators National Cancer Institute (NCI) NIH Protein Technologies International
Status Completed
Phase Phase 2
Study type Interventional
Conditions Breast Cancer, Hot Flashes, Hot Flushes
Intervention type Dietary Supplement, Drug, Other
Interventions soy protein, isoflavones, Tamoxifen, Placebo
Enrollment 112
Start date Mar 1, 2002
Primary completion Apr 1, 2006
Completion Nov 1, 2013
First posted Jan 27, 2003
Last update posted Jul 13, 2016
Countries United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies